Alpha Cognition Inc.
No enriched coverage for $ACOG in the last 7 days.
Opaleye Management Inc. purchased 52,900 indirectly-held shares of Alpha Cognition Inc. (ACOG) at an average of $8.00 ($7.92–$8.00, $0.42M total) across 2 trades over 2026-07-31 to 2026-08-03.
Alpha Cognition Inc. (NASDAQ: ACOG) said the European Patent Office granted a European patent covering a crystalline solid form of benzgalantamine, the active ingredient in ZUNVEYL, for use in treating mild-to-moderate Alzheimer’s disease. The patent covers specific solid form, compositions, manufacturing and medical-use claims, with potential protection into 2042, subject to requirements.
Opaleye Management Inc. purchased 200,086 indirectly-held shares of Alpha Cognition Inc. (ACOG) at an average of $7.82 ($7.80–$7.83, $1.57M total) across 3 trades over 2026-07-22 to 2026-07-23.
Recent ACOG coverage spans insider activity, financial news and corporate actions.
In the last 30 days, ACOG insiders filed 6 SEC Form 4 transactions — 6 purchases ($2.0M) and no sales. The most active reporter was Opaleye Management Inc. with 6 filings.
This is an insider/affiliate accumulation signal, but it is not a fundamental catalyst like earnings or guidance.
The EPO patent grant strengthens Alpha Cognition’s European IP position for ZUNVEYL/benzgalantamine, potentially supporting longer exclusivity and commercialization optionality.
The filing is a new insider buying datapoint for ACOG, but it is indirect and lacks a 10b5-1 plan, limiting signal strength.
The filing is a fresh insider/affiliate accumulation signal, but it is not a fundamental catalyst like earnings or guidance.
Board leadership change via 8-K; likely modest near-term impact unless tied to strategy shifts or governance changes not detailed here.
alphai scores every news story that mentions ACOG with an AI model for sentiment and relevance, and aggregates insider trades from Alpha Cognition Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Opaleye Management Inc. purchased 52,900 indirectly-held shares of Alpha Cognition Inc. (ACOG) at an average of $8.00 ($7.92–$8.00, $0.42M total) across 2 trades over 2026-07-31 to 2026-08-03.
2 min readAlpha Cognition Inc. (NASDAQ: ACOG) said the European Patent Office granted a European patent covering a crystalline solid form of benzgalantamine, the active ingredient in ZUNVEYL, for use in treating mild-to-moderate Alzheimer’s disease. The patent covers specific solid form, compositions, manufacturing and medical-use claims, with potential protection into 2042, subject to requirements.
3 min readOpaleye Management Inc. purchased 200,086 indirectly-held shares of Alpha Cognition Inc. (ACOG) at an average of $7.82 ($7.80–$7.83, $1.57M total) across 3 trades over 2026-07-22 to 2026-07-23.
2 min readOpaleye Management Inc. purchased 152,533 indirectly-held shares of Alpha Cognition Inc. (ACOG) at an average of $6.40 ($6.40–$6.50, $0.98M total) across 2 trades over 2026-06-25 to 2026-06-26.
2 min readAlpha Cognition Inc. (ACOG) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001655923 A1 00-0000000 0001655923 2026-06-16 2026-06-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
3 min readOpaleye Management Inc. purchased 7,685 indirectly-held shares of Alpha Cognition Inc. (ACOG) at an average of $5.96 ($5.91–$5.99) across 3 trades over 2026-06-11 to 2026-06-15.
2 min readOpaleye Management Inc. purchased 30,728 indirectly-held shares of Alpha Cognition Inc. (ACOG) at an average of $5.98 ($5.98–$5.99, $0.18M total) across 2 trades over 2026-06-09 to 2026-06-10.
1 min readOpaleye Management Inc. purchased 10,054 indirectly-held shares of Alpha Cognition Inc. (ACOG) at $5.83 on 2026-06-05.
1 min readOpaleye Management Inc. purchased 70,577 indirectly-held shares of Alpha Cognition Inc. (ACOG) at $5.90 ($0.42M total) on 2026-05-29.
2 min readOpaleye Management Inc. purchased 2,000 indirectly-held shares of Alpha Cognition Inc. (ACOG) at $5.83 on 2026-05-28.
2 min read
